SeekingAlpha · Aug 1, 2026
Bausch Health Companies Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-01. The following slide deck was published by Bausch Health Companies Inc.
NYSE · BHC
Bausch Health Companies Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$6.51
Up+$0.17 (+2.68%)
Updated Aug 15, 2026, 3:46 PM
SID Score
6.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.6B
- P/E ratio
- 7.19
- Dividend yield
- 0.00%
- 52-week range
- $4.33 – $8.69
- Volume
- 2.56M
- Avg. volume
- 2.36M
Price performance
BHC price history
1M range · 0 trading sessions · Daily adjusted prices
BHC does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest BHC news
The latest Smart Investors Daily articles mentioning BHC.
Stock researchCompany · Overview
BHC research
Overview
Company profile and research snapshot.
Company profile
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $8.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 30, 2026 | TRUIST SECURITIES | Hold | — |
| Apr 29, 2026 | TD COWEN | Hold | — |
| Feb 20, 2026 | TD COWEN | Hold | — |
| Jan 27, 2026 | TD COWEN | Hold | — |
| Jan 26, 2026 | TD COWEN | Hold | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Jul 30, 2026
Bausch Health Companies Inc. (BHC) Q2 2026 Earnings Call Transcript
Bausch Health Companies Inc. (BHC) Q2 2026 Earnings Call July 29, 2026 5:00 PM EDTCompany ParticipantsGaren Sarafian - VP & Head of Investor...
Benzinga · Jul 29, 2026
Bausch Health Companies Raises FY2026 Sales Guidance from $10.670B-$10.920B to $10.790B-$11.040B vs $10.773B Est
Bausch Health Companies (TSX:BHC) raises FY2026 sales outlook from $10.670 billion-$10.920 billion to $10.790 billion-$11.040 billion vs $10.773 billion estimate.
Benzinga · Jul 29, 2026
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.06 Estimate, Sales $2.852B Beat $2.679B Estimate
Bausch Health Companies (TSX:BHC) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.06 by 17.76 percent. This is a 38.46 percent increase over earnings of $0.91 per share
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
